Investigational Drug Details
| Drug ID: | D515 |
| Drug Name: | Sarpogrelate |
| Synonyms: | |
| Type: | small molecule |
| DrugBank ID: | DB12163 |
| DrugBank Description: | Sarpogrelate has been investigated for the treatment of Diabetes Mellitus, Diabetic Nephropathy, Coronary Artery Disease, and Renal Insufficiency, Chronic. |
| PubChem ID: | 5160 |
| CasNo: | 125926-17-2 |
| Repositioning for NAFLD: | Yes |
| SMILES: | COC1=CC(CCC2=CC=CC=C2OCC(CN(C)C)OC(=O)CCC(O)=O)=CC=C1 |
| Structure: |
|
| InChiKey: | FFYNAVGJSYHHFO-UHFFFAOYSA-N |
| Molecular Weight: | 429.513 |
| DrugBank Targets: | 5-hydroxytryptamine receptor 2C; 5-hydroxytryptamine receptor 2A |
| DrugBank MoA: | |
| DrugBank Pharmacology: | |
| DrugBank Indication: | |
| Targets: | |
| Therapeutic Category: | |
| Clinical Trial Progress: | |
| Latest Progress: |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0798 | NCT03904836 | PHASE1 | COMPLETED | NO | 2019-01-31 | 2021-02-26 | Details |
| L3634 | NCT06797869 | PHASE2 | RECRUITING | NO | 2025-01-29 | 2025-03-25 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|